14.48 -0.42 (-2.84%)
PFE
Stock Details
Last Trade:14.48 Change:-0.42 (-2.84%) Prev Close:14.90 Open: 14.77 Days Range:14.44 – 14.80 52 Week Range: 11.68 - 20.13 Volume:41300970 P/E: 12.38EPS:1.17
View AllRecent Alerts 07/02/09
Recent Alert on 07/01/09 at 12:19pm
Pfizer Inc (PFE) Updates U.S. Product Labeling for CHANTIX
Pfizer Inc (PFE) Updates U.S. Product Labeling for CHANTIX
Pfizer Inc (NYSE: PFE) has updated the U.S. product labeling for CHANTIX(R) (varenicline), a prescription aid to smoking cessation treatment, to communicate important safety information in a boxed warning as well as in revised warnings and... Read More
Recent Alert on 07/01/09 at 11:09am
FDA to Hold Call Discussing Potential Issues with Pfizer's (PFE) Stop-Smoking Drug, Chantix -CNBC
FDA to Hold Call Discussing Potential Issues with Pfizer's (PFE) Stop-Smoking Drug, Chantix -CNBC
Recent Alert on 07/01/09 at 11:09am
FDA to Hold Call Discussing Potential Issues with Pfizer's (PFE) Stop-Smoking Drug, Chantix -CNBC
FDA to Hold Call Discussing Potential Issues with Pfizer's (PFE) Stop-Smoking Drug, Chantix -CNBC
Recent Alert on 06/30/09 at 5:30pm
Pfizer (PFE) Stops Phase 3 Trial of Sutent in Metastatic Colorectal Cancer
Pfizer (PFE) Stops Phase 3 Trial of Sutent in Metastatic Colorectal Cancer
View AllRecent Press Releases
Press Release on 07/01/09 at 5:08pm
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
Press Release on 07/01/09 at 12:49pm
Pfizer Invites Public to Listen to Teleconference on Important Update Related to Chantix (R) (varenicline)
Pfizer Invites Public to Listen to Teleconference on Important Update Related to Chantix (R) (varenicline)
Press Release on 07/01/09 at 12:16pm
Pfizer Updates CHANTIX (R) (varenicline) Labeling in the United States
Pfizer Updates CHANTIX (R) (varenicline) Labeling in the United States
Press Release on 07/01/09 at 11:30am
Pfizer Launches Medicine Assistance Program for Newly Unemployed
Pfizer Launches Medicine Assistance Program for Newly Unemployed
Press Release on 06/30/09 at 5:01pm
Pfizer Discontinues Phase 3 Trial of Sutent(R) in Metastatic Colorectal Cancer
Pfizer Discontinues Phase 3 Trial of Sutent(R) in Metastatic Colorectal Cancer

